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Abstract
An intronic GGGGCC (G4C2) hexanucleotide repeat expansion inC9orf72 is the most common genetic cause of amyotrophic
lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Repeat-associated non-AUG (RAN) translation of G4C2 RNA can
result in five different dipeptide repeat proteins (DPR: poly GA, poly GP, poly GR, poly PA, and poly PR), which aggregate into
neuronal cytoplasmic and nuclear inclusions in affected patients, however their contribution to disease pathogenesis remains
controversial. We show that among the DPR proteins, expression of poly GA in a cell culture model activates programmed cell
death and TDP-43 cleavage in a dose-dependent manner. Dual expression of poly GA together with other DPRs revealed that
poly GP and poly PA are sequestered by poly GA, whereas poly GR and poly PR are rarely co-localised with poly GA. Dual expres-
sion of poly GA and poly PA ameliorated poly GA toxicity by inhibiting poly GA aggregation both in vitro and in vivo in the chick
embryonic spinal cord. Expression of alternative codon-derived DPRs in chick embryonic spinal cord confirmed in vitro data, re-
vealing that each of the dipeptides caused toxicity, with poly GA being the most toxic. Further, in vivo expression of G4C2 re-
peats of varying length caused apoptotic cell death, but failed to generate DPRs. Together, these data demonstrate that C9-
related toxicity can be mediated by either RNA or DPRs. Moreover, our findings provide evidence that poly GA is a key mediator
of cytotoxicity and that cross-talk between DPR proteins likely modifies their pathogenic status in C9ALS/FTD.
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Introduction
Hexanucleotide repeat expansion (G4C2) in the first intron of
the C9orf72 gene is the most common genetic cause of amyotro-
phic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
The number of repeats is polymorphic, with the most common
number being two but up to 30 repeats have been detected in
healthy controls, whereas disease-affected individuals have
many more repeats, ranging from 70 to several thousand (1,2).
Three pathomechanisms have been proposed. Firstly, reduced
C9orf72 protein levels may inhibit endosomal trafficking, affect-
ing endocytosis and autophagy (3–6). However, C9orf72 knock-
out mice do not manifest motor neuron degeneration (7) and
null-allele mutants have not been detected in ALS or FTD cases.
Secondly, expanded G4C2 RNA transcripts may cause toxicity
by forming RNA foci, which sequester RNA binding proteins,
disabling the RNA processing machinery (8–10). Thirdly, repeat-
associated non-AUG translation of G4C2 or G2C4 RNA can pro-
duce poly GA, poly GP, poly GR, poly PA and poly PR, which have
been detected in the brains of C9orf72 affected expansion car-
riers (11–13). Poly GA, poly GP and poly GR result from sense
transcripts (14–16), whereas poly GP, poly PA and poly PR are
translated from antisense transcript (17–19).
Recent studies provide evidence that DPR proteins are toxic.
In several models, the arginine-rich DPRs poly GR and poly PR
caused nucleolar stress, which has been suggested as a patho-
genic mechanism in ALS and FTD (20,21). However, the contri-
bution of poly GR and poly PR to human disease is controversial
due to their scarcity in C9FTD/ALS brain tissue and their near
absence in post-mortem spinal cord (22). In contrast, poly GA
aggregation is frequently detected in C9FTD/ALS brain tissue
and is associated with neurodegeneration in the frontal cortex
(13). Poly GA is particularly aggregation-prone and generates
predominantly neuronal cytoplasmic inclusions (NCI), which
are also observed in urea fractions from C9FTD/ALS brain tissue
(12). The expression of poly GA impairs neurite outgrowth and
activates caspase-3 through endoplasmic reticulum (ER) stress
(23). More recently, mouse models generated by AAV adminis-
tration via the intracerebroventricular (ICV) route demonstrate
that poly GA aggregates sequester the proteasomal degradation
protein HR23 and impair nucleocytoplasmic transport proteins
leading to neurodegeneration (24).
In this study, we generated vectors encoding 125 repeats of
all five dipeptides from a non-G4C2 sequence and compared
their toxicity to G4C2 expression in transfected human cell lines
and chick embryo spinal cord. Our results show that poly GA is
the most aggregation-prone and toxic of the five DPRs.
Intriguingly, poly PA can suppress poly GA-mediated toxicity by
inhibiting poly GA aggregation. Neurotoxicity in the chick spinal
cord was comparable following G4C2 hexanucleotide and dipep-
tide electroporation, but we failed to detect any dipeptides from
G4C2 repeat constructs, suggesting that both RNA foci and di-
peptide repeats are contributing to the pathogenicity of the
C9orf72 expansion in C9ALS/FTD. Poly PA could also suppress
poly GA-mediated toxicity in vivo. This suggests an interplay be-
tween DPRs that should be considered as a facet of the underly-
ing disease mechanism.
Results
G4C2 repeats cause neurotoxicity in vivo
In order to compare the toxic effects of dipeptide and G4C2 hex-
anucleotide repeats, we electroporated a range of expression
constructs in the chick embryo. To determine whether ex-
panded G4C2 transcripts show length-dependent toxicity
in vivo, EGFP-tagged G4C2 repeat constructs of different repeat
lengths (8x, 38x, 72x and 128x), were electroporated into the
chick spinal cord at embryonic day 2.5 (E2.5). Since the cut-off
repeat number for ‘risk’ is reported to be 30x (2), 8x is considered
to be non-pathogenic and used as a negative control whereas
the 38x, 72x and 128x repeats are considered potentially patho-
genic (Fig. 1A). An EGFP construct was electroporated as a con-
trol. These constructs were designed with the capability to be
transcribed but not translated through conventional AUG-
initiated mechanisms. However, the possibility exists for trans-
lation into dipeptides using non-conventional ‘RAN’ translation
so that both RNA-mediated and dipeptide-mediated toxicity
could result. The electroporated embryos were re-incubated for
24 h until E3.5 and fixed, cryosectioned and immunostained
with anti-GFP antibodies to determine the extent of construct
expression (Fig. 1Ba–e). Terminal uridine nick-end labelling
(TUNEL) was used to visualise apoptotic cells (Fig. 1Bf–j). We ob-
served that EGFP and EGFP-8x electroporated embryos had very
few TUNEL-positive cells on the electroporated side with no
TUNEL-positive cells on the control side. Embryos electropo-
rated with EGFP-38x, EGFP-72x and EGFP-128x constructs
showed TUNEL-positive cells on the electroporated side. A
smaller number of apoptotic cells were also detected on the
non-electroporated side, suggesting that G4C2-mediated toxic-
ity may spread contralaterally.
Toxicity was quantitated by measuring the area occupied by
apoptotic cells as a percentage of the GFP-positive area for each
section, to normalize for the efficiency of transfection. A mean
percentage was then derived for each construct (Fig. 1C) under
each condition. By this measure, embryos electroporated with
EGFP-38x, EGFP-72x and EGFP-128x showed a marked increase in
toxicity compared with either EGFP or EGFP-8x-expressing em-
bryos. The EGFP-38x construct caused significantly higher levels
of toxicity than the EGFP-128x construct. These results demon-
strate that 38x repeats of G4C2 produce the most neuronal
death in the chick embryo, with lesser amounts of cell death
caused by 72x and 128x constructs.
G4C2 hexanucleotide expansions form intranuclear
RNA foci in vivo
One of the key RNA gain-of-function mechanisms associated
with C9ALS/FTD neurodegeneration is the presence of RNA foci
containing G4C2 repeats within neuronal nuclei in ALS and FTD
patients. We analysed the prevalence of these RNA foci in chick
embryos electroporated with G4C2 repeats using a Cy3-tagged
G2C4 probe with fluorescent in situ hybridization. The G4C2-
positive RNA foci were completely absent in the spinal cord sec-
tions from control EGFP, and EGFP-8x expressing embryos but
were abundantly found in cells expressing the longer repeats;
EGFP-38x, EGFP-72x and EGFP-128x (Fig. 1Bk–o). The RNA foci
arising from EGFP-38x repeats were larger than those seen in
EGFP-72x and EGFP-128x expressing embryos (Fig. 1Bs–u) and
correlated with the higher prevalence of apoptotic cells seen
with this construct.
G4C2 hexanucleotide expansion repeats
affect motor neurons
In order to determine any specific effects of the G4C2 hexanu-
cleotide repeat expansions on motor neurons, we assessed the
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effects of G4C2 expression on motor axon projections 48 h post
electroporation. E4.5, electroporated embryos were immunos-
tained with antibodies to GFP and the anti-neurofilament-
associated protein antibody (3A10) (Fig. 2A). EGFP control and
EGFP-8x-expressing embryos were found to extend motor axons
into the limb buds as expected and exhibited very little differ-
ence in the number of motor neurons between the control and
the electroporated sides (< 10%), suggesting negligible toxicity
(Fig. 2B and C). Embryos expressing EGFP-38x, EGFP-72x and
EGFP-128x repeats, however, showed evidence of abnormal
nerve growth, including debundling/defasciculation and trunca-
tion as axon bundles, failed to extend into the periphery
(Fig. 2A). Embryos electroporated with these constructs also had
fewer motor neurons on the electroporated side compared to
the control side (Fig. 2B and C), indicating that motor neu-
rons are susceptible to the G4C2 hexanucleotide repeat-
mediated toxicity which impairs the axonal outgrowth of sur-
viving neurons.
Dipeptide distribution in C9 human brain frontal cortex
To investigate the distribution of DPRs, we first sought to vali-
date antibodies to GA, GP, GR, PA and PR and determine their
abundance and distribution in human cortex samples (n¼ 5)
(Fig. 3Aa–e). Immunofluorescence microscopy confirmed that
poly GA, poly GP and poly GR were usually present within large
cytoplasmic inclusions, whereas poly GR and poly PR dipeptides
were detected within very small intranuclear inclusions. The
percentage of DPR-positive inclusions in frontal cortex
cells (n¼ 50 for each case) was poly GA (46%, 236 3.0), poly GP
(26.8%, 13.462.1), poly GR (9.2%, 4.661.4), poly PA (3.2%,
1.660.5), and poly PR (2.8%, 1.460.5) (Fig. 3Af). Thus, the most
abundant DPR inclusions in the frontal cortex are derived from
RAN translation of the sense strand transcript (GA>GP>GR).
poly GP is also derived from the antisense strand and are far
more common than those derived exclusively from the anti-
sense strand (poly PA and poly PR). These results are consistent
with our previous studies on the spinal cord samples of C9orf72
mutation-positive ALS cases (22).
Characteristic features of dipeptide distributions in vitro
Neurotoxicity in Drosophila models caused by DPR proteins has
been reported for the two arginine-rich DPRs poly GR and poly
PR (20,21). Poly GA has also been suggested to cause neurotoxic-
ity through the ER stress response (23) and the transport factor
Unc119, which is linked to neuromuscular and axonal function,
co-aggregates with poly GA (25). However, the other DPRs, such
as poly GP and poly PA were not investigated. To investigate the
toxicity of all five DPRs, we generated codon-scrambled con-
structs with an ATG translation initiation codon followed by a
sequence encoding 125 dipeptide repeats tagged with EGFP at
the C terminus (Fig. 3B). These constructs included a mixture of
alternative codons with reduced GC content and lacking repeti-
tion to prevent the formation of RNA foci as is observed with re-
petitive G4C2-based constructs. In order to determine the
stability of each codon-scrambled DPR RNA transcripts, we used
semi-quantitative PCR and showed that the levels of EGFP
Figure 1. C9orf72 hexanucleotide repeats cause RNA foci and toxicity in the chick spinal cord. (A) Schematic diagram of the hexanucleotide repeat expressing con-
structs (G4C2x8, x38, x72, x128). (B) Transverse sections of chick embryo spinal cords at embryonic day 3.5 (E3.5) (dorsal at the top), electroporated with EGFP or EGFP-
tagged hexanucleotide repeat constructs as illustrated (E-G4C2x8, x38, x72, x128). (a–e) Spinal cord sections were immunostained with anti-GFP antibody (green). (f–j)
Apoptotic cell death was analysed by TUNEL staining (black). (k–o) G4C2 RNA foci detected by in situ hybridization (white). (p–r) Higher magnification images of corre-
sponding TUNEL-stained sections (h–j). (s–u) Higher power images of corresponding panels in situ hybridized for RNA foci (m–o). Scale bar ¼ 100lm. (C) Quantification
of TUNEL-positive cells (%), normalized to area of GFP fluorescence. Error bars represent the standard error for each sample (***P<0.0001). The data were analysed from
six embryos in three independent sets of experiments.
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mRNA expression were identical for all constructs (Fig. 3B).
HEK-293 cells were transfected with DPRs, and after 48 h, we as-
sessed DPR protein expression levels in HEK-293 cells by west-
ern blotting with the anti-GFP antibody (Fig. 3C). We found that
the GA-EGFP protein was almost completely detergent-resistant
and was retained at the top of the gel. GP-EGFP appeared at
75 kDa, and PA-EGFP was detected at 100 kDa, however, no
GR or PR positive bands could be detected by western blotting.
The failure of GR-EGFP and PR-EGFP detection could be due to
the length of the positively-charged Arginine-rich peptide (125
repeats) which may prevent the protein from running through
the gel (20). To resolve this issue, we used a filter trap assay,
which confirmed that both GR and PR are efficiently expressed
and can be detected as insoluble aggregates on the membrane
(Fig. 3D).
We next sought to determine the subcellular distribution of
GFP-tagged dipeptide proteins (Fig. 3E). GA-EGFP forms large cy-
toplasmic aggregates (Fig. 3Ea) and is occasionally found as ag-
gregated form in the nucleus. The DAPI image shows that the
GA-EGFP aggregates commonly indent a portion of the nucleus.
GP-EGFP is distributed diffusely in both the cytoplasm and the
nucleus (Fig. 3Eb) while PA-EGFP is predominantly in the cyto-
plasm (Fig. 3Ed). GR-EGFP and PR-EGFP are distributed predomi-
nantly within the nucleus and concentrated in granules (Fig.
3Ec and e), in a position consistent with a location in the nucleo-
lus. Thus, DPR-EGFP constructs are expressed at equivalent
levels, and their subcellular distribution within cells is consis-
tent with previous reports (26,27).
Poly GA is the most toxic among the DPRs in
transfected cells
In order to determine whether DPRs cause cellular toxicity, we
have assayed the apoptosis marker poly (ADP-ribose) polymer-
ase (PARP, 116 kDa), which produces an 89 kDa cleavage product
in response to apoptosis. Of the five DPRs PARP cleavage
(89 kDa) is only detected in GA-EGFP transfected cells (Fig. 3F
and G), which agrees with the findings of Zhang et al., that 50
repeats of GA were able to activate apoptosis and caspase-3 ac-
tivation (23). Remarkably, we also detected significant TDP-43
cleavage in GA-EGFP transfected cells (Fig. 3F), since TDP-43
cleavage is a biochemical signature in ALS and FTD (28). Based
on these results, we speculate that GA toxicity may be depen-
dent on the amount of protein expressed. To test this hypothe-
sis, we transfected HEK-293 cells with a range of GA-EGFP
plasmid concentrations (50–1000 ng per 40, 000 cells) and dem-
onstrate that PARP and TDP-43 cleavage is GA-dose responsive,
increasing in parallel to the appearance of high molecular
weight GA-EGFP aggregates on western blot (Fig. 3H). In this
cellular model, we did not observe toxicity from GR-EGFP and
PR-EGFP expression, which suggests that some cell lines may be
resistant to the toxic effects of these DPRs.
Figure 2. Hexanucleotide repeats affect motor neuron survival and motor axon pathways. (A) Transverse sections of E4.5 chick embryos, including spinal cord and pe-
riphery, immunostained for anti-GFP (a–e) and anti-neurofilament (f–j) to show electroporated motor axons on a background of normal nerve projections. (k–o) merged
image between EGFP and 3A10 (neurofilament, red). Inset of boxed areas of the corresponding panels is magnified ten times in (p–t). Arrow indicates truncation and
fasciculation of the axons (r–t). (u–z) Diagrammatic representation of perturbations of axon pathways (red; motor neuron, green; motor neuron outgrowth). (B)
Embryos were electroporated with EGFP-G4C2x8, x38, x72, x128 at E3.5, then transverse sections of embryonic day E4.5 chick embryo spinal cords were immunostained
(a–e) with GFP and anti-Islet-1 antibodies, which detect motor neurons (f–j). (C) The semi-quantitative analysis shows the percentage difference between the number
of motor neuron on the control side and the number of motor neuron on the electroporated side. Scale bar¼100 lm. The data were analysed from six embryos in three
independent sets of experiments.
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Dipeptides cause toxicity in embryonic chick spinal cord
To investigate dipeptide-mediated neurotoxicity in vivo, we ex-
pressed the five scrambled-codon dipeptide constructs in the
chick spinal cord. Each DPR construct was electroporated into
the embryonic chick spinal cord, and the embryos were re-
incubated for 24 h. The embryos were then cryosectioned and
immunostained with anti-GFP antibodies, to determine the ex-
tent of DPR expression, and TUNEL-labelled to assay apoptotic
cell death. Differences were observed between the dipeptides in
the dorsoventral extent of transfection in the spinal cord
(Fig. 4Aa–e) and in the subcellular distribution of DPR proteins
(Fig. 4Ak–o). For example, GA-EGFP and PR-EGFP expression ap-
peared to form aggregates (Fig. 4Aa and k), whereas GP-EGFP,
GR-EGFP and PA-EGFP were expressed diffusely throughout the
neuronal cytoplasm (Fig. 4Al–n). Differences in DPR regional lo-
calization meant that it was impossible to normalize toxicity ac-
cording to the EGFP area in any single section, so manual
counting of TUNEL and GFP-positive cells was used instead.
Embryos electroporated with EGFP alone showed very little tox-
icity, whereas embryos electroporated with GA-EGFP showed
the highest level of toxicity that was significantly different from
the control (P< 0.0001; Fig. 4B). Of the other constructs, there
Figure 3. Poly GA is the most abundant DPR in human cortex and is toxic to cultured cells. (A) The total numbers of DPR-positive cells were counted in the C9orf72-posi-
tive human frontal cortex (n¼5). (a-e) Rabbit anti-DPR antibodies were used for the immunostaining for GA, GP, GR, PA, and PR (Green). DAPI (blue) was used for nu-
clear counterstaining, and (f) 50 cells were counted from each section (n¼5). Scale bar ¼ 5 mm. (B) Schematic diagram of scrambled synthetic DPR, which incorporated
start codon ATG. Artificially synthesized DPR DNAs were cloned into an EGFP expression vector, which generates N-terminal DPR-EGFP fusion proteins. Expression of
DPR-EGFPs was tested in HEK-293 cells. Transcription of mRNA levels of transfected plasmids was assessed by semi-quantitative RT-PCR. (C) Western blot analysis of
total cell lysates showed that poly GA forms a high molecular weight species. (D) Filter trap assay revealed that GA-EGFP, GR-EGFP and PR-EGFP are insoluble. An equal
amount of lysates was loaded on nitrocellulose membranes. Membranes were stained with an anti-GFP antibody. (E) Expression of synthetic 125 repeat DPRs in HEK-
293 cells results in the formation of cytoplasmic (GA-EGFP) or nuclear inclusions (GR-EGFP, PR-EGFP). In contrast, no inclusions were detected in GP-EGFP and PA-EGFP
expressing cells. Scale bar ¼ 5 mm. (F) Western blot analysis of total cell lysates from DPR-expressing cells for anti-PARP (top) and anti-TDP-43 (middle) revealed that
GA-EGFP produced PARP cleavage, a marker of cell death and a 37 kDa TDP-43 cleavage product. GAPDH was used to normalize the protein loading. (G) Quantitative
analysis of PARP western blotting showed that cells bearing inclusions of GA have significantly increased cleaved PARP (***P<0.0001). (H) Dose-response of GA-EGFP
(50–10000 ng/well) was assessed for PARP (top) and TDP-43 (middle) cleavage. The high molecular weight of GA-EGFP (bottom) was increased following the dose of GA-
EGFP plasmids.
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was toxicity in a descending order PR>PA>GR (Fig. 4B), how-
ever GP-EGFP showed negligible toxicity.
Poly GA sequesters other dipeptides
Both sense and antisense RNA foci have been found in the same
cell (27,29). Thus all five dipeptides have the capability of being
expressed in a single cell. Here we demonstrated that poly GP
and poly PA did not aggregate in transfected cells (Fig. 3Eb and d),
but both are found as aggregates in the brain of c9orf72 positive
cases (Fig. 3A). Therefor, we sought to test the hypothesis that
certain DPRs may affect the behaviour of others regarding their
localization, aggregation and toxicity. As poly GA is the most
aggregate-prone, we co-transfected GA-EGFP with other dipep-
tides (GAþGP, GAþGR, GAþPA, GAþPR), and immunostained
cells for the different dipeptides and found that GA can co-
localise with the other DPRs (GP and PA) (Fig. 5A). In order to as-
sess whether such co-localization is detectable in human brain,
we performed double immunostaining with anti-GA and anti-GP
antibodies. We observed that GA was localized in the core of an
inclusion surrounded by GP (Fig. 5B) in 10% of cells containing GA
inclusions (Fig. 5C). Overall, results indicate that GA is a source of
seeding protein, which sequesters GP.
Poly PA inhibits PARP cleavage and aggregation of
poly GA
We further speculated that GA-dependent toxicity might be al-
tered by the presence of other dipeptides, which we then tested
by dual transfection. Interestingly, among the dipeptides, co-
transfection with GA-EGFP and PA-EGFP reduced PARP cleavage
by 50% compared with GA-EGFP and other dipeptides (Fig. 6A
and B). In addition, the 35 kDa cleaved TDP-43 fragment was de-
creased by 50% in double transfected (PA-EGFP with GA-EGFP)
cells. Then, we tested the number of GA aggregates in the
presence of other dipeptides using GA specific monoclonal anti-
body (Fig. 6C). There was a sharp reduction in the numbers of
GA-positive aggregates in co-transfected cells (P< 0.0001) (Fig.
6D).
Poly PA inhibits poly GA toxicity in chick spinal cord
In order to understand the role of PA in GA toxicity, the amount
of PA-EGFP plasmid used for transfection was gradually in-
creased while keeping a constant expression of GA-EGFP and
PARP cleavage was monitored. We found that PARP cleavage
was dramatically reduced by high levels of PA (Fig. 7A). To en-
sure that PA-EGFP itself has an effect on PARP cleavage, a simi-
lar dose response of PA-EGFP transfection was performed
without GA-EGFP, which resulted in no PARP cleavage being de-
tected (Fig. 7B). To further investigate the biological relevance of
these phenomena, we tested the effect of increasing GA-EGFP
expression on its propensity to aggregate. We found that trans-
fection of 100 ng of DNA transfection produced monomeric GA-
EGFP, with a molecular weight of around 60 kDa and showing
multiple bands of GA throughout the gel from 100 ng of GA-
EGFP (Fig. 7C). However, on transfecting 200 ng of GA-EGFP led
to complete aggregation of the DPR that remained on top of the
gel. In contrast, double transfection with increasing concentra-
tions of PA-EGFP with GA-EGFP reduced the amount of aggre-
gated GA-EGFP trapped on top of the gel and increased the level
of monomeric GA-EGFP (Fig. 7D). These results suggest that PA-
EGFP accumulation inhibits GA-EGFP aggregation and toxicity.
In view of the ability of poly PA to rescue poly GA toxicity in
vitro, we also tested this idea in vivo by electroporating chick spi-
nal cord with both GA-EGFP and PA-EGFP plasmids at 2 mg: 2 mg
and 3 mg: 1 mg of GA-EGFP: PA-EGFP dosages in order to compare
their toxicity using the TUNEL assay (Fig. 7Ea–e). We observed a
significant toxic effect with GA-EGFP alone, (Fig. 7Eg) albeit the
Figure 4. Poly GA is most toxic DPR in chick spinal cord. (A) Transverse sections of embryonic day 3.5 (E3.5) chick embryo spinal cords electroporated with DPR con-
structs as labelled (GA, GP, GR, PA and PR) with 4 mg of plasmid, which causes toxicity in the chick spinal cord. (a–e) Expression of DPR detected with GFP
Immunostaining on sections of electroporated spinal cord. (f–j) Cell toxicity of DPRs were assessed by TUNEL assay. (k–o) Merge image of DAPI and DPR. Scale bar ¼
100 lm. (B) Quantitative analysis of TUNEL-positive cells showing that cells bearing inclusions of GA, PR have significantly increased TUNEL positive staining
(***P<0.0001).
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incidence of cell death was lower than the following electropo-
ration with twice the plasmid concentration (Fig. 4A).
Dual transfection with either GA-EGFPþPA-EGFP (2: 2) or
GA-EGFPþPA-EGFP (3: 1) resulted in a more diffuse GFP signal
throughout the cell, an absence of focal aggregates and a signifi-
cant reduction in the number of TUNEL-labelled cells (Fig. 7Ei, Ej
and F). These results suggest that expression of PA-EGFP with
GA-EGFP in the chick spinal cord produced a dose-dependent
reduction of GA-mediated toxicity (Fig. 7F). Immunohistochem-
istry using anti-GA and -PA specific antibodies confirmed ex-
pression of both DPR (Fig. 7G).
DPR versus RNA toxicity of G4C2 hexanucleotide repeat
In this study, we have shown that the expression of both G4C2
hexanucleotide repeats and scrambled alternative-codon DPRs
are both neurotoxic to differing degrees in cellular and in vivo
models, but it is not clear which of these mechanisms is likely
to predominate in ALS and FTD. In order to determine whether
DPR expression contributed to G4C2 toxicity in the chick spinal
cord, we used dipeptide-specific antibodies to compare the ex-
pression of DPRs and G4C2 72x repeats. All of these antibodies
were able to detect DPR inclusions in C9orf72 patient tissues
and chick spinal cords electroporated with scrambled con-
structs (GA-EGFP, GP-EGFP and GR-EGFP) (Fig. 7Hb, f and j), how-
ever, immunostaining on the sections from EGFP-G4C2x72
repeats failed to yield any DPR staining (Fig. 7Hd, h and l). This
result indicates that the neurotoxicity observed in the chick
spinal cord following electroporation of G4C2 repeats must re-
sult purely from an RNA-based mechanism and not from RAN
translation. Overall these results suggest that toxicity can arise
from either G4C2 RNA or dipeptide repeats, with poly GA the
most toxic of the DPR isoforms in our cellular and animal
models.
Discussion
Since the hexanucleotide repeat expansion was discovered in
the first intron region of the C9orf72 gene, several major hypoth-
eses have emerged to explain its toxic mechanism, ranging
from haploinsufficiency, RNA foci formation and DPR-mediated
toxicity. The discovery of DPRs has fueled research not only on
C9 but also the repeat-related diseases such as Fragile X-associ-
ated tremor ataxia syndrome (FXTAS) and myotonic dystrophy
(DM1), which opens up a new aspect of the pathology of neuro-
degenerative disease (30,31). As DPRs have become a key area of
investigation in C9orf72-mediated pathology, we have investi-
gated the potential toxicity of RNA and DPRs using the chick
embryo as an in vivo model.
Here we show that C9orf72 repeat constructs produce toxic-
ity in the chick spinal cord, consistent with our previous, data
in the zebrafish model (10). However, in this case, we found that
the toxicity did not correspond to the length as the G4C2x38 re-
peat showed 50% more toxicity than G4C2x128 (Fig. 1C). We
have previously shown that G4C2x72 repeats were less toxic
than G4C2x38 repeats in SH-SY5Y cells, which is consistent
Figure 5. Crosstalk between DPR proteins: GA sequesters GP. (A) HEK-293 cells were transfected with (GA-EGFPþEGFP, GA-EGFPþGP-EGFP, GA-EGFPþGR-EGFP,
GA-EGFPþPA-EGFP and GA-EGFPþPR-EGFP). Cells were immunostained with specific rabbit antibodies against DPRs (GA, GP, GR, PA and PR; red). Green indicates EGFP-
expressing DPRs and blue shows nuclear counterstaining with DAPI. Scale bar ¼ 5 lm. (B) Human brain sections (temporal lobe) from C9orf72 expansion carriers were
used for double-staining with poly GA (green) against poly GP (red) (n¼3). (C) The percentage of poly GA and poly GP positive cells show that the majority of poly GP ag-
gregates are positive with poly GA on hippocampal neuron (***P<0.0001).
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with our chick embryo model (10). In addition, we have shown
that 38x repeat constructs produce the largest number of RNA
foci, consistent with the large amount of cell death of the con-
structs tested.
In order to investigate the effects of dipeptide-mediated tox-
icity, we surveyed the expression patterns of all of the DPRs in
human post mortem tissue sections from the frontal cortex of
C9orf72 expansion carriers and discovered aggregated forms of
poly GA, poly GP and poly PA in the cytoplasm whereas the poly
GR and poly PR was detected mainly in the nucleus.
Intriguingly, among the DPRs, poly GA was the most frequently
found in the frontal cortex, which is consistent with other re-
ports (13) and was the most aggregate-prone and toxic in our
cellular model (Fig. 3E and C). Poly GA was the only DPR, which
had the potential to produce PARP cleavage, a marker of apopto-
sis, in a dose-dependent manner. TDP-43 cleavage, a key feature
of ALS pathology, also resulted from poly GA over-expression.
Arginine-rich dipeptide poly GR or poly PRs have been reported
as toxic (20,21); currently we cannot rule out the relevance of
the poly GR and poly PR toxicity in our cell model, even though
we found their prevalence to be less than that of poly GA in the
brain. Due to the fact that PARP cleavage has only been found
cells expressing poly GA, which is correlated with TDP-43 cleav-
age, we can conclude that the most toxic DPR is poly GA, at least
in our cell culture system.
Moreover, in vivo injection of the DPR plasmid into the chick
embryonic spinal cord demonstrates that the most toxic species
was poly GA compared with other DPRs (Fig. 4A). These results
match with our cellular data that GA is the most toxic among
the DPRs. There are several reports of the pathological role of
poly GA, suggesting that aggregated poly GA leads to ER stress,
which activates apoptosis in primary neurons (23). In contrast,
poly GA aggregates have been suggested to act as protective
granules which sequester toxic components in the cytoplasm,
enabling cells to sustain during stress (32). In this case, it is im-
portant to compare these results with similar aggregating pro-
tein poly-glutamine (polyQ) diseases, which resemble GA
toxicity (33) in many ways. Firstly, polyQ aggregates of large in-
clusions are proposed as a proximal cause of neurodegeneration
(33). Secondly, the expanded polyQ protein is aggregate-prone
and the expanded poly-glutamine track facilitates the transition
to toxic conformation. Finally, it could cause protein-misfolding
stress such as autophagy or UPR. These routes need to be ad-
dressed in future studies.
Although the toxicity of DPRs is still debated, all DPRs have
been found as aggregated forms in human brain, with occasion-
ally diffuse distribution detected. We have noticed that the sin-
gle expression of poly GP or poly PA in a cell culture model did
not show aggregation, as detected in human brain. However,
when expressed together with poly GA, poly GP or poly PA were
able to form aggregates. The co-expression study of poly GA
with other DPRs demonstrates co-localization within cells, rais-
ing the possibility that poly GA ‘seeds’ DPR aggregation. We
have found that the poly GA was at the core of the aggregate of
poly GP aggregates in the human brain. Mackenzie et al., dem-
onstrated that cytoplasmic poly GA was found in the centre of
the cell being surrounded by aggregated TDP-43 in dentate gran-
ule cells, which is similar to what we have found with poly-GP
(12). Therefore, there might be more preference by those DPR in-
teractions with poly GA (Fig. 5A).
While characterizing the toxic effects of DPRs, we found that
poly PA protected PARP cleavage (Fig. 6A and B). We therefore
further speculate that poly PA is able to decrease poly GA aggre-
gation. We confirmed that the poly GA aggregation was de-
creased by about 40% following poly PA overexpression, which
suggested that poly PA inhibits poly GA aggregation. The bio-
chemical analysis showed that poly PA inhibits poly GA aggre-
gation in a dose-dependent manner. These results may suggest
Figure 6. Poly PA inhibit PARP cleavage and aggregation of poly GA. (A) Dual transfection of GA-EGFP with PA-EGFP decreases PARP cleavage. GA-EGFP (250 ng) with
GP-EGFP, GR-EGFP, PA-EGFP and PR-EGFP (250 ng) were transfected in HEK-293 cells, and total cell lysates were used for PARP and TDP-43 (middle) analysis by western
blotting. (B) Quantitative analysis of cleaved PARP showing that cells bearing inclusions of GAþPA have significantly decreased levels of cleaved PARP (***P<0.0001). (C)
Dual (DPR-EGFPs þ GA-EGFP) transfected HEK-293 cells were stained with anti-GA antibodies (red). Blue represents nuclear counterstaining of DAPI. Scale bar ¼ 10lm.
(D) Quantitative analysis of GA-EGFP positive cells showing that cells are bearing inclusion of GA, PA have significantly decreased GA-EGFP aggregates (***P<0.0001).
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Figure 7. Poly PA inhibits poly GA toxicity in chick spinal cord: DPR versus RNA toxicity of G4C2 hexanucleotide repeats. (A) Cleaved PARP and TDP-43 were assessed in
lysates, of HEK-293 cells co-transfected with GA (250 ng) and increasing concentrations of PA-EGFP (0-1000 ng). (B) PA-EGFP expression did not increase PARP cleavage.
Increasing concentrations of PA-EGFP (0-1000 ng) were transfected without GA-EGFP. (C) High molecular weight GA-EGFP species is increased in a dose-response man-
ner. Total cell lysates from GA-EGFP (50–1000 ng) transfected HEK-293 cells were used for anti-GA western blotting. (D) PA-EGFP inhibits GA-EGFP aggregation. The ap-
pearance of high molecular weight GA-EGFP species is inhibited by a gradual increase of PA-EGFP. (E) PA-EGFP rescues GA-EGFP- mediated toxicity in the chick spinal
cord. Transverse sections of embryonic day 3.5 (E3.5) chick embryo spinal cords (dorsal at top), electroporated with DPR constructs as labelled – GA and PA embryos
were electroporated with 2 mg of plasmid. GA-EGFP: PA-EGFP (2: 2) and GA-EGFP: PA-EGFP (3: 1) were electroporated with different concentrations (mg) of plasmids as in-
dicated. Scale bar ¼ 100 lm. (F) Quantitative analysis of TUNEL-positive cells showing that the number of TUNEL- positive GA-EGFP expressing cells are significantly de-
creased by PA-EGFP expression in chick spinal cord (***P<0.0001). (G) GA-EGFP and PA-EGFP expression in chick spinal cord were detected by immunostaining for GA
and PA. Scale bar ¼ 100 lm. DAPI and GFP show subcellular localization of DPRs by using DPR antibodies. Scale bar¼ 100 lm. (H) Comparison of DPR expression between
synthetic DPR construct and G4C2 repeat construct by DPR immunostaining in chick spinal cord. The GA-EGFP, GP-EGFP, and GR-EGFP constructs (a, e, i) are transfected
with the same amount of EGFP-G4C2x 72 repeat construct (c, g, k). DPR expression levels were compared with specific poly GA, poly GP and poly GR antibodies. Scale
bar ¼ 100 lm. The data were analysed from six embryos in three independent sets of experiments.
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that poly PA is able to compete with poly GA for aggregation.
The double injection of poly GA and poly PA in the chick model
demonstrated similar results that poly PA decreased poly GA
toxicity.
We have previously used the chick embryo to model the
pathological effects of TDP-43 wild-type and mutant con-
structs. We found that TDP-43 mutants caused neurotoxicity,
accompanied by striking defects in axon outgrowth, implying
that cytoskeletal dysregulation may play a role in ALS and
FTD-TDP pathogenesis. Similar phenotypes were observed fol-
lowing over-expression of wild-type and mutant TDP-43 (34),
suggesting that a common mechanism might link C9orf72 and
TDP-43 to ALS and FTLD. In addition, co-expression of poly PA
with poly GA could rescue poly GA-mediated toxicity in vitro
and in vivo (Fig. 7), further suggesting the capacity for DPRs to
interact with one another. Finally, a comparison of RNA-
mediated and DPR-mediated toxicity in the chick spinal cord
in vivo suggested that are both toxic mechanisms in this in vivo
model. These results may suggest that the pathology of DPR is
more complicated than our assumption from individual C9
RNA studies.
Overall, here we demonstrate that over-expression of G4C2
hexanucleotide expansion repeats and in particular of repeat
lengths of 38x confer neurotoxicity in the chick model. The
G4C2 hexanucleotide repeat (38x, 72x and 128x) in particular,
forms RNA foci, affecting motor neurons and motor axon pro-
jections. Although it was difficult to compare directly because of
differences in expression patterns, we found that dipeptide-
encoding constructs caused similar levels of toxicity as G4C2
repeats. Importantly, in our chick model, the expression of
G4C2 repeats did not result in DPRs, suggesting that RNA repeat
expansion mediated toxicity is not through the DPRs. Therefore,
the toxicity of RNA foci and DPRs are not mutually exclusive
and both contribute to the pathomechanism of C9orf72 linked
disease.
Materials and Methods
Dipeptide cloning
Poly GA, poly GP, poly GR, poly PA, and poly PR (125 repeats) se-
quences were synthesized by GeneArt (Life Technologies). The
protein sequences of each dipeptides were uploaded on the
web-based Geneart program and converted to DNA sequence
using a codon optimization process which generates random
DNA sequences of each dipeptides. All plasmid constructs were
re-sequenced and sized later in the experiments to ensure that
there were no rearrangements (Supplementary Material, Fig.
S1). The HA tag was included 5’ of GA and GP. The synthesized
C9RAN DNAs were used for cloning into a lentiviral shuttle vec-
tor which expressing EGFP. The plasmids were used for in vitro
and in vivo transfection study.
Hexanucleotide repeat plasmid constructs
The details of EGFP plasmids containing the GGGGCC hexanu-
cleotide repeat sequence of C9orf72 (G4C2) with 8x, 38x, and 72x
repeats were described previously (10). We have further cloned
128x repeat into the 5’ EGFP vector. These constructs, driven by
a CMV promoter, were used for chick electroporation experi-
ments. pEGFP-C1 expression vector was used to express EGFP as
described previously (34).
Cell culture
HEK-293 cells were maintained in Dulbecco’s modified Eagle
medium (DMEM; Life Technologies) supplemented with 10%
feotal bovine serum (Life Technologies), and maintained at
37 C, 5% CO2. Cells were plated a day before transfection and
the medium was replaced with fresh medium before transfec-
tion using Lipofectamine 3000 (Life Technologies).
Western blotting and immunofluorescence
Five to ten mg of cell lysate from the RIPA fraction and the equiv-
alent liquid volume from the fraction were loaded on gels.
Western blot quantification was performed using ImageJ.
Integrated band intensities were normalized to that of loading
control or the RIPA fraction. Cells were fixed in 4% PFA (Sigma)
at 4 C for 20 min and washed with PBS three times for 10 min.
Cells were then permeabilized using PBS containing 0.1%
TritonX-100 (Sigma) for 5 min at room temperature with gentle
shaking, followed by blocking in PBS containing 1-5% donkey se-
rum for 1 h at room temperature. Cells were then incubated
with primary antibody diluted in blocking solution overnight at
4 C. After washing with PBS, cells were incubated with fluores-
cent secondary antibodies (1: 500) diluted in blocking solution
for 1 h at room temperature. DAPI (Sigma) was used for staining
of nuclei and the slides were mounted in FluorSave
(Calbiochem). To detect insoluble C9RANs, a filter trap assay
was performed. Cells were lysed in RIPA buffer and the protein
concentrations were assessed by DC protein assay kit (Bio-rad;
5000111). Total proteins (2 lg/100ml) were filtered through a cel-
lulose acetate membrane (pore size 0.2 lm) then washed three
times according to a published protocol (36). Aggregates re-
tained on the filter were detected with an anti-GFP antibody.
Human tissue processing
All cases were provided by the MRC London Neurodegenerative
Diseases Brain Bank (Institute of Psychiatry, Psychology and
Neuroscience, King’s College London, UK) and were collected
and distributed according to local and national research ethics
committee approvals (Supplementary Material, Table S1 for
case details). Sections from the frontal cortex were provided as
10% formalin-fixed and paraffin-embedded blocks. To perform
double immunostaining, paraffin was removed with xylene and
sections were rehydrated in an ethanol series (100, 95, 70%) for
3 min each. Slides were incubated in 0.3% Sudan black for 5 min
to quench autofluorescence and washed with water. Antigen re-
trieval was carried out by microwaving for 6 min at maximum
power and 12 min at medium power in 100 mM sodium citrate
buffer (pH 6.0). Non-specific binding sites were then blocked for
20 min using 5% normal donkey serum in PBS.
For immunofluorescence staining, sections were incubated
with primary rabbit antibodies against the five different DPRs
(poly-GA, GP, GR, PR and PA) at a dilution of 1: 100 or monoclo-
nal GA (Millipore MABN889) at 1: 100 overnight in a humid
chamber at 4 C. The C9RAN antibodies were previously charac-
terised (23). After three washes with PBS, sections were incu-
bated with anti-rabbit (Dylight 594) and anti-mouse (Dylight
488) secondary antibodies for 1 h at room temperature. DAPI
(Sigma) was used to counterstain nuclei. Sections were
mounted in Fluorsave. Semi-quantitative and quantitative eval-
uation of C9RANs was performed using a Zeiss Axiovert S100
microscope. Aggregates were also imaged using a Leica
Confocal SP microscope. The number of DPR aggregates was
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counted from fifty DAPI positive cells per case. Statistical analy-
sis was performed with GraphPad Prism software (version 5.0).
Chick embryo preparation
Fertilised Brown Bovan Gold Hen’s eggs (Henry Stewart & Co, UK)
were incubated in a forced draft incubator at 38 C for 2.5 days
(HH14-15) and staged (37). All embryos were treated in accor-
dance with the Animals (Scientific Procedures) Act of 1986, UK.
In ovo electroporation
Expression of constructs was achieved by in ovo electroporation
as described (34,38). Genes of interest were expressed in one-
half of the spinal cord. Briefly, eggs were windowed, and
Tyrode’s solution containing 1% penicillin–streptomycin
(Invitrogen) was added. Plasmid DNA constructs were dissolved
in ddH2O (1–4.0 lg/ll with 0.5% fast green) and pressure-injected
into the lumen of the spinal cord. Platinum electrodes were po-
sitioned in parallel on either side of the spinal cord, and a
square pulse at 20 mV was applied five times for 50 ms at 1 s in-
tervals. In all the experiments, pEGFPC1 expression vector was
used as a control. Eggs were resealed and incubated for 24–96 h,
after which surviving embryos were dissected and fixed using
4% paraformaldehyde for 1–2 h at room temperature.
Chick embryo immunofluorescence
Fixed embryos were washed with PBST (PBS (Invitrogen)þ 0.1%
Triton X-100 (Sigma)) three times and processed through in-
creasing concentrations of sucrose into OCT, snap-frozen and
sectioned at 20 lm. Frozen sections were washed in PBS, per-
meabilised using PBST (1PBSþ 0.5% Triton X-100). Sections
were then blocked using 10% FCS/PBS for 1 h and incubated
with primary antibodies overnight at 4 C (mouse anti-islet1/2
(4D5), 1: 200, DSHB; mouse anti-neurofilament associated pro-
tein (3A10), 1: 200, DSHB; chicken anti-GFP, 1: 1000, Abcam).
Anti-dipeptide antibodies were applied as for human tissue.
Sections or cells were washed again with PBS, three times for
5 min each, before incubation with fluorescent secondary anti-
bodies for 1–2 h at room temperature (anti-rabbit Alexa Fluor
488; anti-mouse Alexa Fluor 568; anti-mouse Alexa Fluor 488,
anti-chicken Alexa Fluor 488, all 1: 1000, all Invitrogen). After fur-
ther washing, sections or cells were mounted using Hard-set
Vectashield with DAPI (Vector Laboratories). Images were cap-
tured using a Zeiss Axioskop microscope with Volocity software.
TUNEL toxicity assay
To assess toxicity, the DeadEnd colourimetric TUNEL (Promega)
system was used to assay apoptotic cells in tissue sections.
Only sections with more than 50% transfection (as detected by
the GFP staining) were used for the assay.). For the hexanucleo-
tide repeat constructs, the GFP area used for a good indicator of
the extent of electroporation, the area occupied by TUNEL-
positive cells were quantified using Fiji software, and expressed
as a percentage of the area of GFP-expression in each section
(quantified in the same way). For DPR constructs, expression
patterns differed markedly between constructs and could not be
standardized according to GFP staining. Therefore, apoptotic
nuclei were manually counted in sections judged to have suffi-
cient electroporation (<50% area). For RNA repeats, data were
grouped from 42 sections across at least six embryos per condi-
tion from three experiments, and for DPR constructs, data were
analysed from 35 sections across at least six embryos from
three experiments. A mean percentage was calculated across
groups and compared statistically using a one-way ANOVA cou-
pled with Dunn’s multiple comparison tests.
Fluorescent in situ hybridization
Cy3-labelled G2C48 RNA probes were synthesized by
Integrated DNA Technologies and used as antisense probes.
Sections were fixed with 4% DEPC PFA for 15 mins, washed
twice with 1x DEPC PBS, permeabilized with 0.3% Triton X-100
(Sigma-Aldrich) in 1x DEPC PBS for 20 min and equilibrated in 1x
SSC with 40% formamide for 5 min. The sections were pre-
hybridized in 200 ml (per slide) of hybridization solution (50%
formamide, 5x SSC, 5x Denhardts, 0.4 mg/ml Torula yeast RNA,
0.1 mg/ml of baker’s yeast) for 2 h at 65 C in humidified cham-
bers. The probes (10 ng/ml) were added to the hybridization solu-
tion and heated at 95 C for 5 min. Hybridization was performed
overnight at 65 C in humidified chambers. The following day,
sections were washed twice with 0.5x SSC, 40% Formamide and
0.1% Tween-20 solution for 30 min at 65 C, then washed 3x
with PBS-T (1x PBSþ 0.1% Triton X-100) and fixed with 4% PFA
for 5 min. For immunostaining with FISH, sections were blocked
with 1% BSA in PBS-T for 1 h, and then sections were incubated
with primary antibodies as above. Nikon fluorescence and con-
focal systems were used for high-resolution imaging.
Semi-quantitative scoring of RNA foci
For electroporated chick embryonic spinal sections, the num-
bers of RNA foci on the transfected side of the spinal cords were
manually counted, using only sections with more than 50% cells
transfected (as detected by GFP staining). The data were ana-
lysed from 20 sections across at least three embryos from
three sets of experiments. Data were therefore binned as sec-
tions with 100 or less foci, 100–200 or 200–300.
Statistics
Statistical analysis was carried out using GraphdPad Prism.
Unpaired two-tailed Mann–Whitney T-test was used to compare
the abundance of TUNEL-stained cells in chick embryos. Data
are presented as mean6SEM. Statistical significance was set at
P< 0.05.
Supplementary Material
Supplementary Material is available at HMG online.
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